EVEROLIMUS MSDS PDF

Acute toxicity: oral toxicity (LD50): > mg/kg (mouse), > mg/kg (rat) – toxicity data from the Abbott Vascular MSDS dated January 16, for Everolimus. SAFETY DATA SHEET. (in accordance with Regulation (EU) /). Everolimus. Version: 1. Revision date: 29/06/ Page 1 of. Material Safety Data Sheet. Section 1 – Product and Company Information. Product Name: Everolimus. Cat. Code: tlrl-eve. Company identification: InvivoGen.

Author: Yogis Mezihn
Country: Austria
Language: English (Spanish)
Genre: Life
Published (Last): 4 May 2007
Pages: 33
PDF File Size: 17.15 Mb
ePub File Size: 6.26 Mb
ISBN: 123-1-31295-261-5
Downloads: 60957
Price: Free* [*Free Regsitration Required]
Uploader: Mezilmaran

Otilonium The metabolism of Everolimus can be decreased when combined with Otilonium. Orlistat The metabolism of Everolimus can be increased when combined with Orlistat.

Chlorpromazine Everolimux serum concentration of Everolimus can be increased when it is combined with Chlorpromazine. Melengestrol The metabolism of Everolimus can be decreased when combined with Melengestrol. Ivermectin The serum concentration of Everolimus can be increased when it is combined with Ivermectin.

Panobinostat The metabolism of Everolimus can be decreased when combined with Panobinostat. Inotuzumab ozogamicin The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Everolimus. Dihydroergocristine The metabolism of Everolimus can be decreased when combined with Dihydroergocristine. Insulin glargine The therapeutic efficacy of Insulin Glargine can be decreased when used in combination evwrolimus Everolimus.

MSDS of Everolimus

Fosphenytoin The metabolism of Everolimus can be increased when combined with Fosphenytoin. SKIN Wear appropriate protective gloves and clothing to prevent skin exposure.

Lamotrigine The metabolism of Everolimus can be decreased when combined with Lamotrigine. Dihydro-alpha-ergocryptine The metabolism of Everolimus can be decreased when combined with Dihydro-alpha-ergocryptine.

  JESTING PILATE HUXLEY PDF

Pentostatin The risk or severity of adverse effects can be increased when Pentostatin is combined with Everolimus. Otamixaban The risk everoolimus severity of bleeding can be increased when Otamixaban evrrolimus combined with Everolimus.

Efavirenz The serum concentration of Everolimus can be decreased when it is combined with Efavirenz.

Acebutolol The serum concentration of Acebutolol can be increased when it is combined with Everolimus. Edetate calcium disodium anhydrous The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Everolimus.

Methyltestosterone The metabolism of Everolimus can be decreased when combined with Methyltestosterone. Ethynodiol diacetate The metabolism of Everolimus can be decreased when combined with Ethynodiol diacetate.

Deoxyspergualin The risk or severity of adverse effects can be increased when Everolimus is combined with Deoxyspergualin. Chlorzoxazone The metabolism of Everolimus can be decreased when combined with Chlorzoxazone. Belinostat The risk or severity of adverse effects can be increased when Everolimus is combined with Belinostat.

Moexiprilat The risk or severity of adverse effects can be increased when Everolimus is combined with Moexiprilat. Dotarizine The metabolism of Everolimus can be decreased when combined with Dotarizine. Bifonazole The metabolism of Everolimus can be decreased when combined with Bifonazole. Ixabepilone The metabolism of Everolimus can be decreased when combined with Ixabepilone. Cyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Everolimus.

Everolimus – DrugBank

It may also affect the fertility of men as well. Erythromycin The metabolism of Everolimus can be decreased when combined with Erythromycin.

Metreleptin The metabolism of Everolimus can be increased when combined with Metreleptin. Cefoperazone The serum concentration of Everolimus can be increased when it is combined with Cefoperazone. Dexverapamil The serum concentration of Everolimus can be increased when it is combined with Dexverapamil. Finasteride The metabolism of Everolimus can be decreased when combined with Finasteride. Lovastatin The metabolism of Everolimus can be decreased when combined with Lovastatin.

  BREVE INTRODUCCION A LA TEORIA LITERARIA JONATHAN CULLER PDF

Indobufen The risk or severity of bleeding can be increased when Indobufen is combined with Everolimus. Ethylmorphine The metabolism of Everolimus can be decreased when combined with Ethylmorphine. Gitoformate The serum concentration of Gitoformate can be increased when it is combined with Everolimus. Acetyldigoxin The serum concentration of Acetyldigoxin can be increased when it is combined with Everolimus.

Everolimus

Norethisterone The metabolism of Everolimus can be decreased when combined with Norethisterone. Antithrombin Alfa The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Everolimus.

Parnaparin The risk or severity of bleeding can be increased when Parnaparin is combined mssds Everolimus. IMO No information available. The information above is believed to be accurate and represents the best information currently available to us. Bendroflumethiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Everolimus.

Draize test, Rabbit, eye: Interferon alfa-n1 The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Everolimus. Benzphetamine The metabolism of Everolimus can be decreased when combined with Benzphetamine.